KEYTRUDA plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution
In Phase 3 CCTG IND.227/KEYNOTE-483 trial, KEYTRUDA plus chemotherapy also demonstrated statistically significant improvements in PFS and ORR compared to chemotherapy alone
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
elanese now offers Zytel Resin, Hytrel TPC, Crastin PBT and Micromax Electronic Inks and Paste following its 2022 acquisition of the majority of the Mobility & Materials (M&M) business from DuPont
The latest extension of Masimo and Philips’ ongoing collaboration will help enable clinicians to make quick and informed decisions without the need for additional monitoring equipment
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
Subscribe To Our Newsletter & Stay Updated
